BioNTech SE has formed a partnership with the State of Victoria in Australia to collaborate on the research and development of potential mRNA-based vaccines and therapies. As part of the partnership, the two will establish a research and innovation center in Melbourne to facilitate the transition of academic research into clinical development. BioNTech plans to set up a clinical scale end-to-end mRNA manufacturing facility based on its BioNTainer solution in Melbourne with the aim of supporting ...